Business Description
Aier Eye Hospital Group Co Ltd
NAICS : 622310
SIC : 8069
ISIN : CNE100000GR6
Share Class Description:
SZSE:300015: Class ACompare
Compare
Traded in other countries / regions
300015.China IPO Date
2009-10-30Description
Aier Eye Hospital Group Co Ltd provides international ophthalmic technology and management services in China. The company offers services in myopia surgery, cataract, pediatric, eye plastic surgery, myopia prevention and control to patients. The group also enables high-standard medical care.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.9 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | 1.28 | |||||
| Interest Coverage | 22.57 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 9.02 | |||||
| Beneish M-Score | -2.55 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.3 | |||||
| 3-Year EBITDA Growth Rate | 16.6 | |||||
| 3-Year EPS without NRI Growth Rate | 7 | |||||
| 3-Year FCF Growth Rate | 10.1 | |||||
| 3-Year Book Growth Rate | 22.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 13.61 | |||||
| Future 3-5Y Total Revenue Growth Rate | 11.17 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.1 | |||||
| 9-Day RSI | 42.59 | |||||
| 14-Day RSI | 47.61 | |||||
| 6-1 Month Momentum % | 21.39 | |||||
| 12-1 Month Momentum % | -11.62 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.37 | |||||
| Quick Ratio | 1.2 | |||||
| Cash Ratio | 0.83 | |||||
| Days Inventory | 32.37 | |||||
| Days Sales Outstanding | 34.8 | |||||
| Days Payable | 73.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.07 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | 23.6 | |||||
| Forward Dividend Yield % | 1.07 | |||||
| 5-Year Yield-on-Cost % | 2.16 | |||||
| 3-Year Average Share Buyback Ratio | -1.1 | |||||
| Shareholder Yield % | 0.17 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.08 | |||||
| Operating Margin % | 25.6 | |||||
| Net Margin % | 17.6 | |||||
| FCF Margin % | 13.83 | |||||
| ROE % | 18.69 | |||||
| ROA % | 11.66 | |||||
| ROIC % | 19.22 | |||||
| ROC (Joel Greenblatt) % | 52.14 | |||||
| ROCE % | 19.49 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 36.48 | |||||
| Forward PE Ratio | 29.42 | |||||
| PE Ratio without NRI | 34.21 | |||||
| Shiller PE Ratio | 62.17 | |||||
| Price-to-Owner-Earnings | 52 | |||||
| PEG Ratio | 1.75 | |||||
| PS Ratio | 6.41 | |||||
| PB Ratio | 6.53 | |||||
| Price-to-Tangible-Book | 12.33 | |||||
| Price-to-Free-Cash-Flow | 46.31 | |||||
| Price-to-Operating-Cash-Flow | 28.78 | |||||
| EV-to-EBIT | 27.99 | |||||
| EV-to-EBITDA | 27.99 | |||||
| EV-to-Revenue | 6.56 | |||||
| EV-to-FCF | 49.57 | |||||
| Price-to-Projected-FCF | 2.33 | |||||
| Price-to-DCF (Earnings Based) | 1.09 | |||||
| Price-to-DCF (FCF Based) | 1.48 | |||||
| Price-to-Median-PS-Value | 0.75 | |||||
| Price-to-Peter-Lynch-Fair-Value | 2.34 | |||||
| Price-to-Graham-Number | 4.32 | |||||
| Earnings Yield (Greenblatt) % | 3.57 | |||||
| FCF Yield % | 2.14 | |||||
| Forward Rate of Return (Yacktman) % | 16.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aier Eye Hospital Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 20,621.485 | ||
| EPS (TTM) (Â¥) | 0.392 | ||
| Beta | 2.35 | ||
| Volatility % | 77.06 | ||
| 14-Day RSI | 47.61 | ||
| 14-Day ATR (Â¥) | 0.693798 | ||
| 20-Day SMA (Â¥) | 15.173 | ||
| 12-1 Month Momentum % | -11.62 | ||
| 52-Week Range (Â¥) | 9.05 - 19.09 | ||
| Shares Outstanding (Mil) | 9,327.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aier Eye Hospital Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aier Eye Hospital Group Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aier Eye Hospital Group Co Ltd Frequently Asked Questions
What is Aier Eye Hospital Group Co Ltd(SZSE:300015)'s stock price today?
The current price of SZSE:300015 is ¥14.30. The 52 week high of SZSE:300015 is ¥19.09 and 52 week low is ¥9.05.
When is next earnings date of Aier Eye Hospital Group Co Ltd(SZSE:300015)?
The next earnings date of Aier Eye Hospital Group Co Ltd(SZSE:300015) is .
Does Aier Eye Hospital Group Co Ltd(SZSE:300015) pay dividends? If so, how much?
The Dividend Yield %  of Aier Eye Hospital Group Co Ltd(SZSE:300015) is 1.07% (As of Today), Highest Dividend Payout Ratio of Aier Eye Hospital Group Co Ltd(SZSE:300015) was 0.41. The lowest was 0.16. And the median was 0.22. The  Forward Dividend Yield % of Aier Eye Hospital Group Co Ltd(SZSE:300015) is 1.07%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers